Skip to main content
SteadySharesSteadySharesSteadyStShares
The market
MarketsDiscover
Follow the money
Super InvestorsPolitician TradesCrypto Desk
Yours
My WealthNews
Settings Sign in to save your work
Open
SteadySharesMarketsDiscoverSuper InvestorsMy WealthPoliticiansCryptoNews
DiscoverSIBN
HealthcareNGMUSD

SI-BONE, Inc.

$0012345678900123456789.0012345678900123456789+2.9%
52w low (est.) $13.79$21.43 52w high (est.)
Market data · updated 1h ago
Market data
Market cap
USD770.79M
52w range
USD11.48 - USD21.89
Beta
0.67
Sector
Healthcare
Data quality
83/100
Valuation
DCF fair value
USD6.95
Margin of safety
-59.4%
Quality & efficiency
Moat score
45/100
Return on equity
-9.6%
Profit margin
-8.1%
Debt / equity
0.24
Growth & analysts
Revenue growth
+11.2%
Analyst target
USD24.13
Target upside
+41.1%
Analysts
8
Run the 10-point checklist before you buy How these numbers are made

About SI-BONE, Inc.

SI-BONE, Inc., a medical device company, develops procedural solutions for compromised bone, grounded in expertise in biomechanical design and anatomy-specific applications in the United States and internationally. It offers a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products. The company also provides IFUSE, a triangular titanium implant with a triangular cross-section and porous surface that stabilizes the joint and facilitates the biological fixation of the bone onto the implant to drive fusion; IFUSE 3D, a triangular titanium implant with a porous surface and fenestrated design to self-harvest bone; IFUSE BONE, which supports and augments the patient's own bone tissue in orthopedic procedures; IFUSE TORQ, an additively-manufactured threaded implant designed to allow for osteointegration, or incorporation of the bone into the implant's porous surface and structure; IFUSE BEDROCK GRANITE, an implant with a machined titanium core and a tulip that attaches to the rod and provides fusion and fixation to the sacroiliac joint as a foundational element for segmental spinal fusion; and IFUSE TORQ TNT, a porous threaded design with lengths capable of spanning the posterior pelvis, passing through the ipsilateral ilium, sacrum, and through the contralateral ilium. The company markets its products primarily with a direct sales force, as well as through third-party sales agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.

Valuation

ValueGrowthProfitHealthIncome28QUALITY
Overall Rating
29
Sell
Sell

Derived from filed metrics · High confidence (83% of the inputs available)

Moat Score45
DCF Intrinsic Value
USD6.95-59.4% downside

Moat, DCF and rating computed by our valuation engine (ported from the original Python model).

Fundamentals

Market Cap
USD770.79M
P/E Ratio
N/A
Dividend Yield
0.00%
Revenue Growth
+11.2%
Profit Margin
-8.1%
ROE
-9.6%
Debt / Equity
0.24
Beta
0.67
vs Healthcare sector:Moat 45 vs 7Yield 0.00% vs 0.3%

Statistics

Similar Stocks · Healthcare

LLY73
$920.00+0.7%
AZN.L72
£105.20+0.6%
UNH71
$492.10+1.6%
JNJ70
$146.20-0.2%

Latest News · SIBN